Clinical Trials on Proliferative Diabetic Retinopathy in Luxembourg
Total 18 results
-
Luxembourg Institute of HealthCompletedDiabetes Distress | type1diabetesLuxembourg
-
Centre Hospitalier du LuxembourgUniversity of Cambridge; Luxembourg Institute of HealthCompletedType1 Diabetes MellitusLuxembourg
-
Centre Hospitalier du LuxembourgCompletedDiabetes Mellitus, Type 1Luxembourg
-
Centre Hospitalier du LuxembourgUniversity of CambridgeCompletedType 1 Diabetes MellitusLuxembourg
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesLuxembourg, Belgium
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesBelgium, Luxembourg
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Belgium, Luxembourg
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom, Austria, Germany, Luxembourg
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom, Austria, Germany, Luxembourg
-
AOTI Ltd.UnknownDiabetic Foot UlcerUnited Kingdom, United States, Germany, France, Luxembourg
-
Medtronic DiabetesCompletedDiabetes Mellitus, Type 1Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
-
University of CambridgeJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsUnknownType 1 Diabetes MellitusAustria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
-
University of HelsinkiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDiabetes Mellitus, Type 1Spain, Luxembourg, Australia, Switzerland, Canada, Germany, Hungary, United States, Czechia, Estonia, Finland, Italy, Netherlands, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Germany, Argentina, Belgium, Brazil, Canada, Chile, Colombia, France, Italy, Korea, Republic of, Luxembourg, Mexico, Netherlands, Russian Federation, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Taiwan, Th... and more
-
AstraZenecaCompletedDiabetesSpain, United Kingdom, Belgium, Portugal, Greece, Luxembourg
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk FactorsUnited States, Australia, Poland, Ukraine, United Kingdom, Belgium, Germany, France, Spain, Argentina, Colombia, Israel, Mexico, India, Canada, Netherlands, Sweden, Malaysia, New Zealand, Estonia, Russian Federation, Hungary, Norway, ... and more
-
Rigshospitalet, DenmarkUniversity College, LondonEnrolling by invitationEnd Stage Liver Disease | Cardiovascular Diseases | Fractures, Bone | Diabetes Mellitus | Renal Insufficiency | Hepatitis B | Hepatitis C | Kidney Failure, Chronic | Proteinuria | HIV | Coinfection | Acidosis, Lactic | AIDSSpain, Switzerland, Germany, United Kingdom, Austria, Sweden, Finland, Israel, Denmark, France, Italy, Iceland, Belgium, Slovakia, Norway, Lithuania, Portugal, Poland, Croatia, Czechia, Greece, Hungary, Luxembourg, Argentina, Belarus, Bosnia... and more